Movatterモバイル変換


[0]ホーム

URL:


GB9404248D0 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
GB9404248D0
GB9404248D0GB9404248AGB9404248AGB9404248D0GB 9404248 D0GB9404248 D0GB 9404248D0GB 9404248 AGB9404248 AGB 9404248AGB 9404248 AGB9404248 AGB 9404248AGB 9404248 D0GB9404248 D0GB 9404248D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9404248A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLCfiledCriticalBoots Co PLC
Priority to GB9404248ApriorityCriticalpatent/GB9404248D0/en
Publication of GB9404248D0publicationCriticalpatent/GB9404248D0/en
Priority to PCT/EP1995/000791prioritypatent/WO1995023596A1/en
Priority to CZ962585Aprioritypatent/CZ258596A3/en
Priority to PL95316040Aprioritypatent/PL316040A1/en
Priority to NZ281633Aprioritypatent/NZ281633A/en
Priority to JP7522708Aprioritypatent/JPH09509675A/en
Priority to EP95910550Aprioritypatent/EP0749301A1/en
Priority to AU18502/95Aprioritypatent/AU691583B2/en
Priority to SK1132-96Aprioritypatent/SK113296A3/en
Priority to ZA951781Aprioritypatent/ZA951781B/en
Pendinglegal-statusCriticalCurrent

Links

Classifications

Landscapes

GB9404248A1994-03-051994-03-05Pharmaceutical formulationsPendingGB9404248D0 (en)

Priority Applications (10)

Application NumberPriority DateFiling DateTitle
GB9404248AGB9404248D0 (en)1994-03-051994-03-05Pharmaceutical formulations
SK1132-96ASK113296A3 (en)1994-03-051995-03-02Adhesive free topical pharmaceutical formulation
NZ281633ANZ281633A (en)1994-03-051995-03-02Topical wipe or wrap containing a non-steroidal anti-inflammatory drug (nsaid) in a 2-4c alcohol
CZ962585ACZ258596A3 (en)1994-03-051995-03-02Topic pharmaceutical preparation without adhesive
PL95316040APL316040A1 (en)1994-03-051995-03-02Pharmaceutic compositions
PCT/EP1995/000791WO1995023596A1 (en)1994-03-051995-03-02Adhesive free topical pharmaceutical formulations
JP7522708AJPH09509675A (en)1994-03-051995-03-02 Pharmaceutical prescription
EP95910550AEP0749301A1 (en)1994-03-051995-03-02Adhesive free topical pharmaceutical formulations
AU18502/95AAU691583B2 (en)1994-03-051995-03-02Adhesive free topical pharmaceutical formulations
ZA951781AZA951781B (en)1994-03-051995-03-03Pharmaceutical formulations

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GB9404248AGB9404248D0 (en)1994-03-051994-03-05Pharmaceutical formulations

Publications (1)

Publication NumberPublication Date
GB9404248D0true GB9404248D0 (en)1994-04-20

Family

ID=10751332

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB9404248APendingGB9404248D0 (en)1994-03-051994-03-05Pharmaceutical formulations

Country Status (10)

CountryLink
EP (1)EP0749301A1 (en)
JP (1)JPH09509675A (en)
AU (1)AU691583B2 (en)
CZ (1)CZ258596A3 (en)
GB (1)GB9404248D0 (en)
NZ (1)NZ281633A (en)
PL (1)PL316040A1 (en)
SK (1)SK113296A3 (en)
WO (1)WO1995023596A1 (en)
ZA (1)ZA951781B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP0858805A3 (en)*1997-02-131998-09-02National Research Institute of Chinese MedicineTransdermal preparations of oxicams
ES2275525T3 (en)1999-07-122007-06-16Capnia Incorporated APPLIANCE TO RELIEF HEAD PAIN, RHINITIS AND OTHER COMMON AFFECTIONS
US20070039615A1 (en)1999-11-082007-02-22Capnia, IncorporatedMethods and apparatus for treating rhinitis
US20060172017A1 (en)1999-11-082006-08-03Capnia, IncorporatedMethods and apparatus for the enhanced delivery of physiologic agents to tissue surfaces
US10285910B2 (en)2001-10-122019-05-14Aquestive Therapeutics, Inc.Sublingual and buccal film compositions
US8765167B2 (en)2001-10-122014-07-01Monosol Rx, LlcUniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8603514B2 (en)2002-04-112013-12-10Monosol Rx, LlcUniform films for rapid dissolve dosage form incorporating taste-masking compositions
US7357891B2 (en)2001-10-122008-04-15Monosol Rx, LlcProcess for making an ingestible film
US11207805B2 (en)2001-10-122021-12-28Aquestive Therapeutics, Inc.Process for manufacturing a resulting pharmaceutical film
US20110033542A1 (en)2009-08-072011-02-10Monosol Rx, LlcSublingual and buccal film compositions
US20190328679A1 (en)2001-10-122019-10-31Aquestive Therapeutics, Inc.Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
WO2004060347A2 (en)*2002-09-032004-07-22Transform Pharmaceuticals, Inc.Pharmaceutical propylene glycol solvate compositions
US7927613B2 (en)2002-02-152011-04-19University Of South FloridaPharmaceutical co-crystal compositions
JP4906233B2 (en)2002-03-012012-03-28ユニバーシティー オブ サウス フロリダ Multi-component solid phase containing at least one active pharmaceutical ingredient
CN100360117C (en)*2002-06-212008-01-09转化医药公司Pharmaceutical compositions with improved dissolution
GB0518769D0 (en)*2005-09-142005-10-19Medpharm LtdTopical formulations
HU227970B1 (en)2007-07-102012-07-30Egis Gyogyszergyar NyrtPharmaceutical compositions containing silicones of high volatility
MX2011004454A (en)*2008-10-312011-08-15Moberg Derma AbTopical composition comprising a combination of at least two penetration enhancing agents.
TR200907179A1 (en)2009-09-182011-04-21Sanovel İlaç San. Ve Ti̇c. A. Ş. Flurbiprofen and muscle relaxant combinations
US9149959B2 (en)2010-10-222015-10-06Monosol Rx, LlcManufacturing of small film strips
EP2468270A1 (en)*2010-12-212012-06-27GALENpharma GmbH(R)-2-(3-fluoro-4-phenylphenyl)propionic acid for use in the treatment of skin diseases
HUE046750T2 (en)2011-05-032020-03-30Aponia Laboratories IncTransdermal compositions of ibuprofen and methods of use thereof
EP2793855B1 (en)2011-12-232015-12-16Sanovel Ilac Sanayi Ve Ticaret Anonim SirketiFlurbiprofen formulations
WO2013095319A2 (en)2011-12-232013-06-27Sanovel Ilac Sanayi Ve Ticaret Anonim SirketiFormulations of flurbiprofen and diacerein
EP2793856B1 (en)2011-12-232015-12-16Sanovel Ilac Sanayi Ve Ticaret Anonim SirketiOrally-disintegrating formulations of flurbiprofen
US10045935B2 (en)2012-07-312018-08-14Egis Pharmaceuticals PlcTransdermal formulation containing COX inhibitors
US11154535B2 (en)2012-07-312021-10-26Egis Pharmaceuticals PlcTransdermal formulation containing COX inhibitors
US11007161B1 (en)2014-12-312021-05-18Eric MorrisonIbuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10596117B1 (en)2014-12-312020-03-24Eric MorrisonLipoleosomes as carriers for aromatic amide anesthetic compounds
US10561627B2 (en)2014-12-312020-02-18Eric MorrisonIbuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US11273131B2 (en)2016-05-052022-03-15Aquestive Therapeutics, Inc.Pharmaceutical compositions with enhanced permeation
JP7653218B2 (en)2016-05-052025-03-28アクエスティブ セラピューティクス インコーポレイテッド Enhanced Delivery Epinephrine Compositions
WO2019113625A1 (en)*2017-12-112019-06-20Meat & Livestock Australia LtdTransdermal analgesic formulation
ES2835399B2 (en)*2019-12-202022-03-23Univ Jaen Procedure for obtaining a textile material carrying molecules of pharmacological interest and material thus obtained

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB119646A (en)*1917-10-051919-07-04Hendrik Johannes Chr HengeveldWadding for Curing Rheumatism.
GB1191645A (en)*1966-10-051970-05-13American Gage & MachRecording Apparatus
GB2075837B (en)*1980-05-141984-03-14Hisamitsu Pharmaceutical CoTopical pharmaceutical gel containing anti-inflammatory analgesic agents
JPS57140711A (en)*1981-02-261982-08-31Teika Seiyaku KkPoultice for anti-inflammatory and analgesic use and its preparation
JPH0662401B2 (en)*1985-04-251994-08-17久光製薬株式会社 Ketoprofen-containing patch
DE3522550A1 (en)*1985-06-241987-01-02Klinge Co Chem Pharm Fab SPRAYABLE PHARMACEUTICAL PREPARATION FOR TOPICAL APPLICATION
JPS6399866A (en)*1986-10-171988-05-02石田 賢司Lint cloth having drug coated surface and its production
JP2570342B2 (en)*1987-12-011997-01-08日産化学工業株式会社 External solution
EP0331382B1 (en)*1988-02-291992-09-09Pfizer Inc.Transdermal flux enhancing compositions
US5061724A (en)*1989-07-181991-10-29Sheldon GertnerMethod for treating arthritically inflamed body joints, particularly joints having gouty arthritis
US5093133A (en)*1990-01-241992-03-03Mcneil-Ppc, Inc.Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
AU8927191A (en)*1990-10-051992-04-28Analgesic AssociatesPrevention or treatment of sunburn using the s(+) isomer of flurbiprofen
JPH1143831A (en)*1997-07-221999-02-16Murata Mach LtdSpinning device

Also Published As

Publication numberPublication date
SK113296A3 (en)1997-05-07
CZ258596A3 (en)1996-12-11
AU1850295A (en)1995-09-18
ZA951781B (en)1995-09-05
PL316040A1 (en)1996-12-23
NZ281633A (en)1998-04-27
EP0749301A1 (en)1996-12-27
WO1995023596A1 (en)1995-09-08
JPH09509675A (en)1997-09-30
AU691583B2 (en)1998-05-21

Similar Documents

PublicationPublication DateTitle
AP9500733A0 (en)Pharmaceutical formulations
EG23826A (en)Pharmaceutical formulations
GB9404248D0 (en)Pharmaceutical formulations
GB9523752D0 (en)Pharmaceutical formulations
GB9407386D0 (en)Pharmaceutical formulation
GB9402203D0 (en)Pharmaceutical formulation
IL112521A0 (en)Pharmaceutical formulation
GB9405856D0 (en)Pharmaceutical formulation
GB9416599D0 (en)Pharmaceutical formulation
GB9408053D0 (en)Pharmaceutical preparation
GB9311030D0 (en)Pharmaceutical formulations
GB9323399D0 (en)Pharmaceutical formulations
ZA96392B (en)Pharmaceutical formulations
GB9413542D0 (en)Pharmaceutical formulations
GB9500978D0 (en)Pharmaceutical formulations
GB9417953D0 (en)Pharmaceutical formulations
GB9408163D0 (en)Pharmaceutical formulations
GB9408151D0 (en)Pharmaceutical formulations
GB9401738D0 (en)Pharmaceutical formulations
GB9408162D0 (en)Pharmaceutical formulations
GB9408161D0 (en)Pharmaceutical formulations
GB9426113D0 (en)Pharmaceutical formulations
GB9414216D0 (en)Pharmaceutical formulations
GB9408164D0 (en)Pharmaceutical formulations
GB9606372D0 (en)Pharmaceutical formulations

[8]ページ先頭

©2009-2025 Movatter.jp